US64135M1053
US64135M1053
Neurogene Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | -- | 925.000 | -- |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 103.328.000 | 83.530.000 | 23.7% | |
| Operating Income | -103.328.000 | -82.605.000 | 25.1% |
| Pretax Income | -90.351.000 | -75.144.000 | 20.2% |
| Net Income Common Stockholders | -90.351.000 | -75.144.000 | 20.2% |
| -- | -- | -- | |
| -- | -- | -- |